Retatrutide
Triple receptor (GIP / GLP-1 / glucagon) agonist research peptide for metabolic studies.
Price for 1 lyophilized vial · $6.00 / mg
Retatrutide is a triple hormone receptor agonist targeting GIP, GLP-1, and glucagon receptors. It represents an advanced area of metabolic research and is offered as a high-purity lyophilized research peptide.
Ingredients
Retatrutide (≥98% purity by HPLC). 10 mg lyophilized peptide per vial. No non-active ingredients.
Directions
For research use only. Reconstitute per study protocol. Store lyophilized at 2–8°C, protected from light.
Warnings
NOT FOR HUMAN OR ANIMAL CONSUMPTION. Research use only. Not approved for human use. Not intended to diagnose, treat, cure, or prevent any disease.
Shipping Information
- • Dispatched within 24 hours on business days
- • Discreet, temperature-aware packaging
- • Tracking provided on every shipment
- • Free shipping to Canada and the US on orders over $150
- • Members: free Canada/US shipping from $75
- • Otherwise $12 Canada, $25 US. International is $40
Third-party lot report
Certificate of analysis
Independent test for this vial size. Changing size loads that lot’s report.
- Lab
- Janoshik Analytical
- Task
- #86681
- Sample
- Retatrutide 10 mg
- Amount found
- 11.53 mg
- Purity
- 99.499%
- Analyzed
- 7 Nov 2025
Specifications
Customer Reviews
Excellent quality and consistent results across multiple batches.
Satisfied with the product and how it was packaged.
Clean reconstitution and consistent quality. Would order again.
Good value for the research being conducted. Fast shipping.
We have ordered several times and the quality has been consistent every time.
Related Products
Semaglutide
1 vial · 5 mg – 30 mg
GLP-1 receptor agonist research peptide studied for appetite regulation and metabolic health.
Tirzepatide
1 vial · 10 mg – 60 mg
Dual GIP / GLP-1 receptor agonist research peptide studied for metabolic physiology.
Tesamorelin
1 vial · 10 mg
Stabilised GHRH analog studied for visceral adipose tissue and metabolic research.